Quick Answer
Cosmos Health Inc. reported Total Revenue of $54.43 million for fiscal year 2024.
Cosmos Health Inc. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $54.43M +2.0% |
$53.38M +6.0% |
$50.35M -10.5% |
$56.24M +1.5% |
$55.41M +39.6% |
$39.68M +7.0% |
| Net Income | -$16.18M +12.7% |
-$18.54M -34.1% |
-$13.83M -73.7% |
-$7.96M -1070.0% |
$820.8K +124.9% |
-$3.30M +63.6% |
| Diluted EPS | -$1.17 +45.6% |
-$2.15 +93.5% |
-$33.16 -39.7% |
-$23.74 -39666.7% |
$0.06 +124.0% |
-$0.25 +63.2% |
| Total Assets | $54.31M -17.7% |
$66.01M -3.0% |
$68.04M +37.6% |
$49.43M +12.7% |
$43.84M +83.6% |
$23.88M +15.4% |
| Cash and Equivalents | — | — | $20.75M +7142.8% |
$286.5K -54.4% |
$628.4K +1530.6% |
$38.5K -95.5% |
| Long-Term Debt | — | — | — | — | $10.77M | $0.00 |
| Stockholders Equity | $24.53M -31.9% |
$36.04M -8.3% |
$39.28M +797.0% |
$4.38M +205.2% |
-$4.16M +35.6% |
-$6.46M -94.8% |
| R&D Expense | $533.3K +223.5% |
$164.9K | — | — | — | — |
| Operating Income | -$15.54M +28.8% |
-$21.83M -192.1% |
-$7.47M -64.9% |
-$4.53M -267.0% |
$2.71M +1161.1% |
-$255.8K +79.2% |
| Gross Profit | $4.31M -0.9% |
$4.35M -27.0% |
$5.96M -28.5% |
$8.33M +3.4% |
$8.06M +120.1% |
$3.66M +52.0% |
| Shares Outstanding | 23.60M +48.5% |
15.90M +50.1% |
10.59M +1443.1% |
686,283 -94.7% |
13.07M +1.6% |
12.86M -6.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $17.11M | +37.9% | +16.0% |
| Net Income | September 30, 2025 | -$5.35M | +36.1% | -89.3% |
| Diluted EPS | September 30, 2025 | -$0.17 | +62.2% | -70.0% |
| Total Assets | September 30, 2025 | $69.49M | +7.7% | +12.4% |
| Cash and Equivalents | September 30, 2025 | $889.4K | — | +182.3% |
| Long-Term Debt | September 30, 2021 | $3.02M | — | -70.5% |
| Stockholders Equity | September 30, 2025 | $23.13M | -33.9% | -11.8% |
| R&D Expense | September 30, 2025 | $18.3K | — | -75.4% |
| Operating Income | September 30, 2025 | -$1.82M | +18.8% | +31.2% |
| Gross Profit | September 30, 2025 | $2.60M | +115.7% | +123.6% |
| Shares Outstanding | September 30, 2025 | 31.87M | +37.0% | +7.2% |
- Cosmos Health Inc. reported Total Revenue of $54.43 million for fiscal year 2024.
- Cosmos Health Inc. showed an increase of +2.0% in Total Revenue compared to the prior fiscal year.
- Cosmos Health Inc. reported Net Income of -$16.18 million for fiscal year 2024.
- Cosmos Health Inc. showed an increase of +12.7% in Net Income compared to the prior fiscal year.
- Cosmos Health Inc. reported Diluted EPS of $1.17 per share (loss) for fiscal year 2024.
- Cosmos Health Inc. showed an increase of +45.6% in Diluted EPS compared to the prior fiscal year.
- Cosmos Health Inc. reported Total Assets of $54.31 million for fiscal year 2024.
- Cosmos Health Inc. showed a decrease of -17.7% in Total Assets compared to the prior fiscal year.
- Cosmos Health Inc. reported Cash and Equivalents of $20.75 million for fiscal year 2022.
- Cosmos Health Inc. showed an increase of +7142.8% in Cash and Equivalents compared to the prior fiscal year.
- Cosmos Health Inc. reported Long-Term Debt of $10.77 million for fiscal year 2020.
- Cosmos Health Inc. reported Stockholders Equity of $24.53 million for fiscal year 2024.
- Cosmos Health Inc. showed a decrease of -31.9% in Stockholders Equity compared to the prior fiscal year.
- Cosmos Health Inc. reported R&D Expense of $533.3 thousand for fiscal year 2024.
- Cosmos Health Inc. showed an increase of +223.5% in R&D Expense compared to the prior fiscal year.
- Cosmos Health Inc. reported Operating Income of -$15.54 million for fiscal year 2024.
- Cosmos Health Inc. showed an increase of +28.8% in Operating Income compared to the prior fiscal year.
- Cosmos Health Inc. reported Gross Profit of $4.31 million for fiscal year 2024.
- Cosmos Health Inc. showed a decrease of -0.9% in Gross Profit compared to the prior fiscal year.
- Cosmos Health Inc. reported Shares Outstanding of 23.60 million shares for fiscal year 2024.
- Cosmos Health Inc. showed an increase of +48.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: